WishBone Medical today said it will launch its growth control plating system for kids at the end of September this year. The growth control plating system is a single-use procedure kit in sterile packaging that is designed to treat angular limb deformities in children. Physicians can use the growth control plates to redirect the growth […]
WishBone Medical inks deal to distribute Bone Solutions OsteoCrete
WishBone Medical confirmed a private label distribution agreement with Bone Solutions, Inc. (BSI) for worldwide rights within pediatric orthopedics to license and sell OsteoCrete. OsteoCrete, a magnesium-based bone void filler, is designed to assist with bone repair and regeneration. It is the first device of its kind in the orthopedic market with 510(k) approval from […]
WishBone Medical acquires CSpine
WishBone Medical said late last week that it acquired Indiana-based spine and orthopedic implant and instrument maker CSpine in an undisclosed deal. Warsaw, Ind.-based WishBone Medical said that its acquisition of CSpine will help the company enter a key segment in pediatric orthopedics and address the needs of children with spinal deformities. “Our foundation supporting […]
Wishbone Medical picks up pediatric device maker Response Ortho
WishBone Medical said this week that it acquired Turkish pediatric fixation device maker Response Ortho for an undisclosed amount. Istanbul-based Response’s portfolio includes 30 pediatric orthopedic systems; WishBone had eight before the acquisition, the Warsaw, Ind.-based company said. Eighteen of the Response Ortho products are cleared or approved for the U.S. market. Wishbone said it’s opursuing […]
Vascular Dynamics taps ex-Ellipse Tech CEO Roschak as chief exec | Personnel Moves December 15, 2017
Vascular Dynamics said early this month it tapped former NuVasive Inc. (NSDQ:NUVA) exec and Ellipse Technologies CEO Ed Roschak as its new president and chief executive. Prior to joining Mountain View, Calif.-based Vascular Dynamics, Roschak served as prez and CEO of Ellipse Technologies, which he saw through a $410 million acquisition by NuVasive. He then took up […]
